40 results
SC 14D9
STSA
Satsuma Pharmaceuticals Inc
5 May 23
Tender offer solicitation
8:17am
be available, including continuing to pursue its strategy as a standalone company or pursuing potential strategic or financing transactions with third parties … to the Company’s business, operations, assets, financial condition, earnings, ownership structure, management, strategy, competitive position, current, historical
SC14D9C
STSA
Satsuma Pharmaceuticals Inc
17 Apr 23
Written communication relating to third party tender offer
4:02pm
by terminology such as “believe,” “may,” “will,” “should”, “predict”, “goal”, “strategy”, “potentially,” “estimate,” “continue,” “anticipate,” “intend … affect the financial condition, results of operations, business strategy, short-term and long-term business operations and objectives and financial
8-K
2vqa0yu
17 Apr 23
SNBL to Acquire Satsuma Pharmaceuticals
6:34am
8-K
EX-2.1
5h3lb9hn079 nzx
17 Apr 23
SNBL to Acquire Satsuma Pharmaceuticals
6:34am
8-K
EX-99.1
vgi29l6i jy9ery6gc8
17 Apr 23
SNBL to Acquire Satsuma Pharmaceuticals
6:34am
8-K
EX-99.2
vehr8h95ccqk0n
20 Dec 22
Satsuma Pharmaceuticals Provides STS101 Development Program and Corporate Update
4:19pm
8-K
EX-99.1
4jw88bc5rrjb31z6
30 Nov 22
Other Events
4:00pm
424B3
78atp9ae4e7nklb tfk
6 May 21
Prospectus supplement
12:00am